This report presents analyses that reveal insights about pharmaceutical manufacturers and their products. This information will enable FDA to better prevent and mitigate quality issues that may lead to drug shortages and supply chain vulnerability. Overall, this report provides a comprehensive picture of the state of pharmaceutical quality for U.S. consumers and patients who have the expectation for safe,
effective, and high-quality medicines.

Download the full report here